Merrill A. Mcpeak - 20 Feb 2024 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Director
Signature
/s/ Merrill A. McPeak
Issuer symbol
IOVA
Transactions as of
20 Feb 2024
Net transactions value
+$2,287,500
Form type
4
Filing time
20 Feb 2024, 19:52:18 UTC
Previous filing
08 Dec 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Purchase $2,287,500 +250,000 +356% $9.15 320,150 20 Feb 2024 Direct F2, F4
holding IOVA Common Stock 248,633 20 Feb 2024 By Trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by a family trust for which the reporting person is a trustee.
F2 Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.
F3 Such number does not include 103,159 deferred restricted stock units, which are vested but not yet issued.
F4 Consists of 30,150 shares held in Keogh retirement account plus 40,000 shares as a result of exercised stock options plus 250,000 shares acquired in this offering.